trial · primary record
Treprostinil Palmitil Inhalation Powder
Pulmonary Hypertension
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 344 |
| Primary completion | 2028-12-30 |
| Primary endpoint | Change in 6 Minute Walk Distance (6MWD) Measured at Peak Exposure From Baseline to Week 24 |
| Registry ID | NCT07179380 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:35.950Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07179380
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.